Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ApoGraft-01 long-term follow-up study
MOH_2018-01-15_000756Phase 2Not yet recruiting
- Sponsor
- Select Biotherapeutics
- Start
- Jan 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ApoGraft in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Select Biotherapeutics. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
ApoGraft
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on MOH_2018-01-15_000756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-01-15_000756.